17 results
Long-Term PEITHO Results #EBM #EM #IM #PCC #PEITHO #PE #PulmonaryEmbolism #Embolism #RebelEM
Long-Term PEITHO ... Results #EBM #EM ... #IM #PCC #PEITHO
Causes of Dyspnea by System #Diagnosis #EM #IM #PCC #Dyspnea #ShortnessOfBreath #Differential #Algorithm #Ddxof
System #Diagnosis #EM ... #IM #PCC #Dyspnea ... Differential #Algorithm #Ddxof
Pleural Effusion - Workup, Diagnostic Algorithm #Diagnosis #EM #IM #PCC #Pleural #Effusion #Transudative #Exudative #Differential #Algorithm
Algorithm #Diagnosis #EM ... #IM #PCC #Pleural ... Lights #Criteria #Ddxof
Algorithm and Causes of an Elevated Hemidiaphragm #Diagnosis #Radiology #EM #IM #PCC #Elevated #Hemidiaphragm #ElevatedHemidiaphragm #Diaphragm
Diagnosis #Radiology #EM ... #IM #PCC #Elevated ... Differential #Algorithm #Ddxof
Common Causes of the Different Categories of Dizziness #Diagnosis #PrimaryCare #EM #IM #Differential #Dizziness #Vertigo #Disequilibrium
#PrimaryCare #EM ... #IM #Differential ... Lightheadedness #Table #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... CalcitoninGeneRelatedPeptideAntibody #Results #NEJM ... #NEJM
Nikolsky’s Sign - Febrile & Positive Nikolsky’s Sign: Patients in this group have the potential to
sick (Fever + Rash ... #Clinical #EM #IM ... #Derm #Nikolsky
Fremanezumab for the Preventive Treatment of Chronic Migraine - Adverse Events in the Safety Population, According
to Trial Group #EBM ... #Neuro #IM #Fremanezumab ... AdverseEvents #NEJM ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... CalcitoninGeneRelatedPeptideAntibody #NEJM
A 27-year-old man with a 2-year history of recurrent, painful skin lesions. A diagnosis of hidradenitis
#Clinical #Derm ... #IM #Hidradenitis ... HidradenitisSuppurativa #NEJM